Ireland’s Carrick Therapeutics raises $95 million in funding round

Irish cancer treatments provider Carrick Therapeutics Ltd has raised $95 million in a funding round from investors including U.S. financial services company Cambridge Innovation Capital Plc.

The round was led by US-based ARCH Venture Partners and Woodford Investment Management with participation from Cambridge Enterprise, Evotec AG, GV (Google Ventures) and Lightstone Ventures, alongside CIC.

Cambridge Innovation Capital said that it’s another circulating immune complexes investment forged through its strong links with Cambridge Enterprise and the University of Cambridge because Carrick Therapeutics combines a management team with a strong and broad-based approach to tackling the development of new cancer therapies.

On September 23, 2016, UK-based University of Cambridge Engineering Department raised 720 million pounds funding from Cambridge Enterprise fund IV, together with a private investor.